Health Diagnostics

Dermatologic Diagnostics Co. Castle Biosciences Collabs with MRF

Castle Biosciences will sponsor Miles for Melanoma 5K events and annual galas across the U.S.

Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced its continued collaboration with the Melanoma Research Foundation (MRF), a non-profit organization leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.

MRF Miles for Melanoma and 2021 Galas:

The MRF Miles for Melanoma 5K run/walks are community events held across the United States, both virtually and in-person, to raise funds that support critical research for viable melanoma treatments. Participants include melanoma patients, survivors, caregivers and supporters. Castle Biosciences is a sponsor of the upcoming events taking place in Cleveland, St. Paul, Minn., Philadelphia, Boston and San Francisco.

Additionally, Castle Biosciences is a sponsor of the 2021 MRF galas, taking place in Chicago, Denver and New York, in celebration of courageous melanoma survivors and those in the medical community who are making a difference in the fight against melanoma through exemplary patient care, cutting-edge research or scientific leadership.

“The important work of the MRF to accelerate medical research while advocating for the melanoma community would not be possible without the generous support of corporate sponsors like Castle Biosciences,” said Kyleigh LiPira, M.B.A., chief executive officer of the MRF. “We are grateful for their partnership and applaud their commitment to keeping patients at the forefront of their business.”

“At Castle, we are committed to improving the lives of patients with skin cancer, and it is at the core of everything we do,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “So, we are proud to further our collaboration with the Melanoma Research Foundation. Their important work in the areas of research, advocacy and education is critical for patients living with melanoma and their families.”

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to

Related posts

Carrum Health Taps Pallav Sharda as Chief Platform Officer

PR Newswire

Veracyte to Acquire HalioDx for Global Cancer Diagnostics Growth

Business Wire

AI Solutions Provider Imbio Partners with Heart&Lung Health

PR Newswire